异染性白质营养不良
发病年龄
医学
儿科
疾病
内科学
白质营养不良
病理
作者
Christiane Kehrer,Saskia Elgün,Christa Raabe,Judith Böhringer,Stefanie Beck-Wödl,Andrea Bevot,Nadja Kaiser,Lüdger Schöls,Ingeborg Krägeloh‐Mann,Samuel Groeschel
出处
期刊:Neurology
[Ovid Technologies (Wolters Kluwer)]
日期:2021-01-12
卷期号:96 (2)
被引量:37
标识
DOI:10.1212/wnl.0000000000011047
摘要
Objective
To compare disease progression between different onset forms of metachromatic leukodystrophy (MLD) and to investigate the influence of the type of first symptoms on the natural course and dynamic of disease progression. Methods
Clinical, genetic, and biochemical parameters were analyzed within a nationwide study of patients with late-infantile (LI; onset age ≤2.5 years), early-juvenile (EJ; onset age 2.6 to <6 years), late-juvenile (LJ; onset age 6 to <16 years), and adult (onset age ≥16 years) forms of MLD. First symptoms were categorized as motor symptoms only, cognitive symptoms only, or both. Standardized clinical endpoints included loss of motor and language functions, as well as dysphagia/tube feeding. Results
Ninety-seven patients with MLD were enrolled. Patients with LI (n = 35) and EJ (n = 18) MLD exhibited similarly rapid disease progression, all starting with motor symptoms (with or without additional cognitive symptoms). In LJ (n = 38) and adult-onset (n = 6) patients, the course of the disease was as rapid as in the early-onset forms, when motor symptoms were present at disease onset, while patients with only cognitive symptoms at disease onset exhibited significantly milder disease progression, independently of their age at onset. A certain genotype-phenotype correlation was observed. Conclusions
In addition to age at onset, the type of first symptoms predicts the rate of disease progression in MLD. These findings are important for counseling and therapy. Classification of Evidence
This study provides Class II evidence that in patients with MLD, age at onset and the type of first symptoms predict the rate of disease progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI